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The Issue 
Bio-based fuels represent one of the most viable alternatives to petroleum-based fuel to 
meet transportation needs in the 21
st century. The biofuel industry is in its infancy in 
Canada but shows considerable growth opportunity. The international interest in biofuels 
due to environmental and energy security concerns could result in a large and profitable 
export market for Canadian biofuel producers. Many industry participants are beginning 
to use biotechnology in their production processes to lower costs. Such use means they 
will be forced to contend with the unclear international regulation of trade in the products 
of  biotechnology.  Substantially  different  rules  have  been  created  by  the  Cartagena 
Protocol on Biosafety to the Convention on Biological  Diversity,  which governs only 
trade in biotechnology products, and the World Trade Organization, which governs trade 
in all goods. The inconsistencies of the regulatory situation create significant risks for 
biofuel producers, as their products may be blocked from important export markets.  
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Implications and Conclusions 
The Canadian biofuel industry shows considerable export potential due to its agricultural 
and technological resources. Due to the unclear regulatory situation for trade in products 
of  biotechnology,  if  the  Canadian  industry  adopts  biotechnology  in  order  to  lower 
production costs, there is a significant  chance its products will face import bans in a 
number of important foreign markets. Investors must be aware of this risk before making 
additional investments in biotechnology applications and production facilities. Further, it 
is important that industry participants work to have regulatory issues addressed before 
they impede trade.  
The Biofuel Industry and Biotechnology 
Biofuels, such as ethanol and biodiesel, are produced from renewable biomass and are 
more environmentally friendly to use than are fossil fuels. They can be directly substituted 
for  petroleum-based  fuels  in  gasoline  and  diesel  engines.  The  use  of  biofuels  for 
transportation has attracted considerable attention in recent years, but their use actually 
pre-dates the use of petroleum-based fuels. When Rudolf Diesel first demonstrated his 
compression engine in 1898, he used peanut oil for fuel. In the 20
th century, however, 
petroleum  fuels  quickly  replaced  bio-based  fuels  due  to  their  low  cost,  availability, 
efficiency and consistency (Werner, 2003). Biofuels have become increasingly attractive 
because of their renewability and availability, and the environmental benefits they offer.  
It is widely recognised that eventually the world’s petroleum reserves will be exhausted 
and new sources of energy will be needed. Biofuels are made from renewable sources 
such as sunflower seeds, corn, soybean, rapeseed and wheat. By substituting consumption 
away from petroleum fuel and onto biofuels, countries could reduce their dependency on 
imported oil – a particularly important point for the United States. Governments also see 
biofuels  as  a  way  to  better  utilize  agricultural  resources,  thereby  increasing  prices  of 
commodities and therefore their farmers’ income. However, the primary motivation for 
the  increased  interest  in  bio-based  fuels  outside  the  United  States  is  concern  for  the 
environment, especially with regard to urban air pollution and global warming – both of 
which are contributed to significantly by the burning of fossil fuels for transportation. 
When  total  lifecycle  emissions  are  considered,  depending  on  the  production  methods 
utilized, biofuels can reduce greenhouse gas emissions by up to 90 percent compared to 
petroleum fuels. In addition, toxic substances in emissions are also reduced (Walsh, 2000) 
Thus far, governments have played a very large role in the development of the biofuel 
industry. Canada has followed in the footsteps of the European Union, the United States, 
Brazil and others, providing large subsidies to encourage development and growth of the 
industry. Under the Climate Change Plan, the Government of Canada has implemented a 
variety of programs to encourage increased biofuel adoption. Some of these programs 
include eliminating the excise tax on ethanol, providing grants and loan guarantees to Current Agriculture, Food & Resource Issues  L. J. Loppacher 
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encourage construction of ethanol and biodiesel facilities, undertaking research projects 
and creating public awareness campaigns to encourage biofuel adoption (Climate Change 
Canada, 2004). 
The major justification for this subsidization in Canada and the  majority of other 
countries that follow similar policies is the desire to correct the market failure pertaining 
to the environmental damage caused by the externalities associated with using petroleum 
fuels. It is also viewed by some, especially in the EU, as a good way to diversify the 
agricultural sector. In addition to subsidization, some countries are beginning to enact 
regulations mandating minimum levels of biofuel adoption. The most prominent example 
of this is the European Union, which has put in place the EC Directive for the Promotion 
of Liquid Biofuels, requiring that 5.75 percent of the fuel market must be supplied by 
biofuels by 2010 (Koerbitz, 2004). Although individual countries in the EU are adopting a 
wide range of measures to achieve this goal, one commonality is that, given their rural 
economic development goals, imports are not a desirable option. 
One of the most significant impediments to the development of a sustainable biofuel 
industry is the high cost of production of biofuels when compared to petroleum-based 
fuels. Although there are benefits to using biofuels, such as lower emissions and in some 
cases better vehicle performance, consumers are not willing to pay a large price premium 
for  these  fuels.  The  most  recent  estimates  state  that  U.S.  corn-based  ethanol  is 
economically viable at oil prices of $60/barrel and biodiesel is economically viable at 
$80/barrel (The Economist, April 20, 2006). It is only recently, during a period of record-
breaking high oil prices, that biofuel production has become economically viable without 
large subsidies. The long-term persistence of these prices is uncertain, and the powerful 
biofuel lobby will fiercely resist any reduction in subsidies that have been in place since 
the inception of the industry. 
Many people involved in the Canadian biofuel industry, including scientists, investors 
and government officials, believe that biotechnology could be a vital tool in reducing the 
cost  of  producing  biofuels  (OECD,  2001).  The  successful  development  of  a  biofuels 
industry based on biotechnology would require, however, that the industry contend with 
the  differing  regulatory  approaches  to  biotechnology  around  the  world  and  an 
international trade law system that, thus far, has been unable to reconcile these approaches 
(Kerr and Loppacher, 2005). Inconsistencies in the regulatory environment could severely 
restrict the growth of an export industry.  
The ability of a firm to export its product could be a central factor in profitability 
calculations  when  considering  a  new  investment.  Evidence  has  shown  that  exploiting 
economies of scale could be another significant factor that will help reduce production 
costs. However, expansion may result in more production than can be absorbed by the 
Canadian market; hence the need to find international markets. 
Biotechnology could be used in a number of ways to lower the production costs of 
biofuels. The first approach could be to genetically modify the biomass to be converted Current Agriculture, Food & Resource Issues  L. J. Loppacher 
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into the biofuel. The objective would be either to increase yields or to produce biomass 
that has characteristics that make it easier and less costly to convert to biofuel. The second 
approach would be to use biotechnology to create enzymes/fungi/bacteria to be used in the 
conversion process. The objective would be to increase the efficiency of the conversion 
process, primarily by lowering the amount of energy required in the process, decreasing 
the time required or increasing the yield. For example, a Canadian company, Iogen, has 
pioneered a process that uses biotechnology to convert waste cellulose (such as straw) into 
ethanol in an energy efficient manner.  As the materials used are waste products from 
agricultural production, input costs can decrease significantly as they have a much lower 
opportunity cost (The Economist, May 12, 2005).  
Regardless  of  the  approach  taken  to  utilize  biotechnology,  after  the  conversion  is 
complete, the amount of GM material remaining in the biofuel would be extremely small. 
Even  given  this  small  amount,  however,  countries  may  attempt  to  regulate  biofuels 
produced using biotechnology differently from the way they regulate biofuels produced 
without  using  biotechnology.  The  director  of  the  Austrian  Biofuel  Institute,  Werner 
Koerbitz (2004), has stated that in the event that even a fraction of the Canadian industry 
began to try to export biodiesel produced using GM canola, countries in the European 
Union  would do everything in their power to stop entry into their market.  While this 
position is likely a guise for providing protection to their domestic industry, the problems 
it will create for North American exporters could be substantial.  
International Trade Law and Biotechnology 
International trade law is a vital component of an efficient international trading system. 
Individuals  and  firms  around  the  world  have  benefited  from  the  effectiveness  of  this 
system. In many cases, it quickly and easily accommodates new products into the mix of 
internationally traded goods. Biotechnology, however, has presented problems  for this 
system due to its novel characteristics, which result in unknown long-term risk factors. In 
the face of this uncertainty, countries around the world have taken significantly different 
regulatory approaches to biotechnology and this has resulted in the evolution of divergent 
trade regimes. The EU has taken an extremely cautious approach and from 1998 to 2003 
had a moratorium on the approval of genetically modified organisms (GMOs) and their 
importation. Even  after the removal of the  moratorium in July 2003, their regulations 
remained far more restrictive than those of, for example, the United States and Canada. 
The World Trade Organization is the primary organization for creating and enforcing 
international  trade  law.  The  WTO  is  primarily  concerned  with  limiting  the  ability  of 
governments to respond to requests for protection from domestic firms; it has been unable 
to  deal  effectively  with  the  issue  of  calls  for  protection  from  environmentalists  and 
domestic consumers (Isaac and Kerr, 2003b). As a result of these perceived deficiencies in 
the  WTO,  many  countries  began  considering  the  creation  of  a  new  system  that  was 
directed  towards  the  protection  of  the  environment.  In  the  case  of  biotechnology,  the Current Agriculture, Food & Resource Issues  L. J. Loppacher 
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result  was  a  multilateral  environmental  agreement  (MEA),  the  Cartagena  Protocol  on 
Biosafety  to  the  Convention  on  Biological  Diversity,  more  commonly  known  as  the 
Biosafety Protocol (BSP). The BSP entered into force on September 11, 2003 after 50 
countries, including the EU, ratified it. As of February 2006, 132 countries had ratified the 
protocol. Notably, the world’s major users of agricultural biotechnology have not ratified 
it. The United States was never part of the BSP process because it has not ratified the 
overarching  Rio  Declaration  on  Environment  and  Development,  and  Canada  and 
Argentina, both signatories to the convention, have not ratified it. The BSP could have a 
deleterious effect on how products using biotechnology are regulated and traded. 
WTO Rules 
The WTO and its predecessor the General Agreement on Tariffs and Trade (GATT) were 
created with the very narrow mandate of removing barriers to international trade through 
the creation, monitoring and enforcement of market access rules (Isaac and Kerr, 2003a). 
The  WTO  has  recognized  that,  in  certain  circumstances,  safety  regulations  to  protect 
consumers may be needed that may impede international trade. It has also recognized that 
the ability of governments to enact these safety regulations must be constrained to ensure 
that  they  are  not  being  used  as  illegitimate  barriers  to  trade.  WTO  rule-making  now 
extends to issues related to food safety and protection of the environment.  
One of the most important underlying principles of the WTO is non-discrimination. 
An important concept that is an integral part of the principle of non-discrimination is that 
of “like products” or “like goods”, which states that goods are to be grouped according to 
their end-use and product characteristics, not according to their production and processing 
methods (PPMs). This concept applies with regard to not only biotechnology but also 
labour standards, cultivation practices, pollution emissions or other factors that do not 
physically alter the end product. The underlying, trade-enhancing rationale of the concept 
of “like goods” is that it prevents a more developed nation – whose domestic standards 
will almost always be higher – from using these standards as an excuse to erect a trade 
barrier to protect its producers from imports from developing countries (Isaac and Kerr, 
2003a).  
The  WTO  Agreement on the  Application of Sanitary and  Phytosanitary Measures 
(SPS Agreement) and the Agreement on Technical Barriers to Trade (TBT Agreement) 
allow member countries to adopt trade-restricting measures to protect human, animal and 
plant health and the environment, but place limitations on when and how these measures 
can be applied. The SPS Agreement outlines when and how WTO members can deny 
market access to particular exporters to reduce risks arising from:  
•  the  entry,  establishment  or  spread  of  pests,  diseases,  disease-carrying 
organisms or disease-causing organisms; Current Agriculture, Food & Resource Issues  L. J. Loppacher 
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•  additives,  contaminants,  toxins  or  disease-causing  organisms  in  food, 
beverages or feedstuffs; 
•  diseases carried by animals, plants or products thereof (WTO, 1994). 
The TBT Agreement addresses technical regulations and standards, as well as testing and 
certification procedures that countries enact to protect their citizens. Two key principles of 
both the TBT and SPS agreements are that safety measures must be applied in a manner 
that does not unnecessarily obstruct trade and that the standards adopted by member states 
should be based on international measures established by international standard-setting 
bodies. In addition, both agreements require that,  where applicable, national measures 
should  be  scientifically  justifiable.  However,  because  the  TBT  Agreement  deals  with 
topics  such  as  labelling  due  to  consumers’  right  to  know,  the  scientific  justification 
principle is considerably weaker in the TBT Agreement than the SPS Agreement. The 
SPS Agreement allows countries to not follow the principle of non-discrimination and to 
place  restrictions  on  specifically  targeted  countries.
1  The  TBT  Agreement,  however, 
requires that countries follow the principle of non-discrimination when dealing with “like 
goods”. If an end product is to have different technical regulations, testing procedures or 
labelling  requirements  than  are  required  for  a  similar  product,  it  must  have  some 
characteristic that differentiates it. The role of these two agreements is clear: to ensure 
countries can still erect barriers to trade when needed to protect their citizens but also to 
ensure there is a legitimate justification for doing so. 
In the case of biofuels, there appears to be no legitimate justification for a ban on the 
basis that biotechnology has been used in their production. Traditional claims against 
products  of  biotechnology  relate  to  one  of  two  concerns.
2  The  first  is  that  there  is 
insufficient information available to determine the long-run health risks associated with 
consumption  of  GM  material.  The  second  concern  relates  to  the  protection  of  the 
environment. Some groups believe that GM plants could pose an unacceptable risk to 
biological  diversity  by  creating  super-weeds,  cross-mingling  with  non-GM  plants  or 
causing mutations in organisms that eat the plants (such as insects). These arguments are 
not applicable to biofuels. With regard to the first concern, biofuels are not intended for 
human or animal consumption so there is no risk to human or animal health. It also cannot 
reasonably be argued that biofuels pose a risk to the environment. As mentioned above, 
biofuels are highly processed products that would contain only minute amounts of GM 
material. As such, they pose no risk of harming plants, organisms that feed on plants or 
biological diversity. Furthermore, due to the very small amount of GM material remaining 
in the biofuel, there would be no evidence to support a claim that biofuels produced using 
biotechnology  are  significantly  different  from  biofuels  produced  without  using 
biotechnology; therefore, they could not be treated differently under trade regulations – 
they would be considered “like products”. Under these agreements and the risk analysis 
framework that underlies them, there is only a very small chance that a ban on biofuel Current Agriculture, Food & Resource Issues  L. J. Loppacher 
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imports would found to be WTO-compliant (Kerr and Loppacher, 2004). A trade ban of 
this nature is precisely what the WTO rules were designed to prevent. 
Biofuels, Biotechnology and  
the Cartagena Protocol on Biosafety 
The international law created in the Biosafety Protocol regarding permissible regulation of 
biotechnology  is  very  different  from  that  in  the  WTO.  The  BSP  “seeks  to  protect 
biological diversity from the potential risk posed by living modified organisms resulting 
from  modern  biotechnology”  (Secretariat  of  the  Convention  on  Biological  Diversity, 
2004a, p. 1). The BSP specifically embraces the use of the “precautionary principle”. The 
precautionary principle states that lack of evidence proving a product is unsafe does not 
indicate that the product is safe. It is a reversal of the traditional approach of “innocent 
until proven guilty”. Hathcock (2000) argues that the precautionary principle requires an 
impossible  burden  of  proof  for  new  products.  He  also  suggests  that  “[i]n  effect,  the 
application of the precautionary principle would negate the input of science and allow … 
decisions to be made by risk managers on an arbitrary basis that would overrule risk 
assessment,  regardless  of  the  data  supporting  a  conclusion  of  safety”  (p.  256).  The 
precautionary principle is reflected in Article 10.6 of the BSP, which states:  
Lack  of  scientific  certainty  due  to  insufficient  relevant  scientific 
information and knowledge regarding the extent of the potential adverse 
effects of a living modified organism … shall not prevent that Party from 
taking a decision, as appropriate, with regard to the import of the living 
modified organism  ….  (Article 10.6, Cartagena Protocol on Biosafety, 
2001) 
The BSP also very specifically bases its rules on processes – modification of genetic 
material. As a result, characteristics of the final product are not the only deciding factor, 
unlike the rules under the WTO. In addition, due to the acceptance of the precautionary 
principle, the BSP allows countries to adopt a provisional measure with no obligation to 
review it after a certain amount of time (Isaac, Phillipson and Kerr, 2002).  
Although a ban on biofuels produced using biotechnology would almost certainly not 
be justifiable under the WTO rules, under the BSP rules, it may. Although there is no 
evidence that these products would pose a danger to human, animal or plant health or the 
environment, the BSP specifically states that lack of evidence shall not prevent a party 
from taking actions to avoid or minimize potential adverse effects. The BSP principle that 
allows a country’s import restrictions on a product to be based on its PPMs rather than its 
end characteristics will allow parties to restrict or block the import of biofuels produced 
using  biotechnology,  regardless  of  the  risk  those  products  present.  This  creates  the 
potential  for  countries  to  put  protectionist-motivated  trade  barriers  in  place  under  the 
guise of sanitary barriers. Current Agriculture, Food & Resource Issues  L. J. Loppacher 
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Which Laws Will Rule? 
The BSP and the WTO obviously have provisions that contravene one another. Which 
system will take precedence in international law is an extremely complicated matter. For a 
more detailed discussion, see  Loppacher (2005).  The WTO created the  Committee on 
Trade and the Environment to help clarify the relationship between the WTO and MEAs. 
Despite frequent meetings, the committee has not reached a consensus on how this could 
or should be done. A major factor in the settlement of disputes will be the strength of the 
dispute-settlement mechanisms enshrined in these agreements. A significant weakness of 
the BSP is its lack of a binding dispute-settlement procedure. The protocol “envisages 
procedures and mechanisms to promote compliance of Parties with their obligations and 
address the cases of non-compliance” (emphasis added) (Secretariat of the Convention on 
Biological  Diversity,  2004b,  p.  23).  The  protocol  uses  compulsory  arbitration  or 
conciliation  to  promote  compliance,  but  compliance  is  voluntary  and  there  are  no 
punishment mechanisms for cases where countries choose not to comply. As the WTO 
does have a binding dispute-settlement procedure, the WTO will likely be the forum for 
meaningful dispute resolution.  
If the BSP is challenged at the WTO, the case will be extremely complex, take a long 
time to be decided and involve many members of the WTO. For example, in a case that 
could serve as a primer to a direct challenge to the BSP, the United States, Canada and 
Argentina  have  brought  a  case  against  the  European  Communities  regarding  their 
moratorium  on  the  approval  of  genetically  modified  organisms.  In  their  defence,  the 
European Union will surely contend that they are acting within their rights as a party of 
the BSP. This case has already proved that it will be very complex, with Australia, Brazil, 
Chile,  Columbia,  India,  Mexico,  New  Zealand  and  Peru  all  requesting  to  participate 
(WTO, 2004). Although the panel is given a general timeframe of six months to issue 
their report, timeframes set by the panel have been repeatedly delayed, and as of March 
2006 a final report had still not been issued but was expected no later than the end of 
September 2006 – over two years after the panel’s formation (WTO, 2006). An interim 
report was issued in February of 2006; this report is confidential and released only to the 
parties  involved.  While  the  findings  may  change  before  the  final  ruling  is  released, 
available information suggests the interim report generally supported the complainants’ 
position.  
A direct challenge to the BSP will likely be even more complex. It is not unreasonable 
to assume every major agricultural trader that was not part of the complaint, including 
exporters and importers,  would request involvement  as third parties in the panel.  The 
severity of the issue would not be lost on any of the players. A decision in favour of the 
BSP could radically change the WTO, allowing decisions to be based on premises other 
than sound science  and a  rules-based approach.  However, a decision against the  BSP 
could very negatively affect the image of, and support for, the WTO. Input on the issue is Current Agriculture, Food & Resource Issues  L. J. Loppacher 
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likely to come from the Committee on Trade and the Environment, officials from the BSP 
and  officials  from  the  international  experts  committees  recognized  by  the  SPS.  The 
panel’s task will be enormous: determining if and how a MEA that contravenes the WTO 
principles  and  text  can  be  accommodated.  In  addition,  due  to  the  implications  of  the 
decision, it will almost surely be appealed by the losing members. There is no precedent 
set as to how this issue will play out but the dispute will be long, costly, involve many 
players, be highly contentious and drastically affect the relationships among trade, the 
environment and consumer calls for protection (Isaac and Kerr, 2003b). 
Implications for the Canadian Biofuel Industry 
Like  many  industries  in  Canada,  if  the  biofuel  industry  is  to  exploit  the  comparative 
advantage it holds in biofuel production, it will have to exploit economies of scale that 
could result in more production than the local market can absorb. Canada has significant 
potential in this market both due to high capacity in biomass production that can be used 
as an input to biofuels and due to the Canadian industry’s technological capabilities. For 
example, Canada is one of the world’s largest producers of canola oil and wheat – both of 
which can be transformed into biofuels. In addition, Canada is producing some of the 
major innovative breakthroughs in the international industry, such as Iogen’s production 
process that efficiently converts waste cellulose into biofuel (The Economist, May 12, 
2005).  
Part of Canada’s comparative advantage will be derived from using biotechnology in 
the  production  of  biofuels.  The  Canadian  industry  will  be  forced  to  contend  with 
conflicting international rules regulating trade in products of biotechnology. The WTO, 
which requires legitimate justification for trade bans made to protect consumers’ right to 
know and human, animal or plant health, would likely find a ban on biofuels produced 
with biotechnology to be incompliant with its rules. The BSP, however, allows decisions 
to be made based on the PPM of a product and allows countries to apply the precautionary 
principle.  Given  these  provisions,  a  ban  on  biofuels  would  likely  be  found  to  be  in 
compliance with the BSP. As the European Union works to deny importers access to their 
market in order to assist their farmers, they will likely invoke their rights under the BSP to 
keep products from Canada (and most likely also the United States) out of their market. A 
challenge to this ban at the WTO would likely take many years and there is no guarantee 
of a favourable outcome or that the EU would comply with a WTO ruling.  
The  Canadian  industry  faces  a  difficult  trade-off.  If  they  chose  to  adopt 
biotechnology, they may be able to lower their costs of production sufficiently to reduce 
their dependence on subsidies and make their industry competitive with petroleum fuels. 
If they do this, however, they  would be subject to  considerable uncertainty regarding 
access to important markets such as the EU. Coordination with the U.S. industry will be 
important, as it is likely they too will adopt biotechnology. At present, it is unlikely the 
Canadian industry will turn away from using biotechnology in their production process. Current Agriculture, Food & Resource Issues  L. J. Loppacher 
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Consequently, they must be proactive in finding a way to resolve this trade issue before 
they look to export their products and find that they cannot. 
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Endnotes 
1 It would not be reasonable to place a restriction on all exporters, as risk factors, such as 
climate or disease-management practices, would not be uniform across all exporting 
countries. 
2 There is also a third concern related to the use of biotechnology, to do with the ethics of 
“playing God” by manipulating genes in ways that natural breeding does not allow 
(Gaisford et al., 2001). This issue will not be dealt with in this paper. 